Navigation Links
Merrimack Pharmaceuticals To Present Preliminary Clinical Data For Novel Therapies Targeting Molecular Pathways In Advanced Cancers
Date:9/18/2012

CAMBRIDGE, Mass., Sept. 18, 2012 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) today announced that research evaluating two novel compounds for advanced cancers, including breast, ovarian, gastric and bladder, will be presented at the ESMO 2012 Congress (European Society for Medical Oncology ), Sept. 28 – Oct. 2 in Vienna, Austria. The medicines are some of the first therapies developed using Merrimack's proprietary scientific approach – Network Biology – focusing not on gene expression but on underlying cancer signals that trigger tumor growth.

"At Merrimack Pharmaceuticals, we believe the key to finding new treatment options for cancer is to start closer to the source of the problem – with signals in the cancer cell that turn specific processes on and off, triggering tumor growth and drug resistance," said Robert J. Mulroy, President and Chief Executive Officer, Merrimack Pharmaceuticals. "By charting and modeling these molecular pathways and signals, we can identify the most sensitive points from which to attack the cancer and then develop medicines and companion diagnostics to disrupt or slow tumor growth."

Therapy and Poster Overview:

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... One of the most extensive, widely cited digital ... now available to high school and junior college students and ... international society for optics and photonics , announced today that ... Library available to high schools for free and two-year ... to all areas of life in today’s world,” said SPIE ...
(Date:11/24/2014)... The new video, “ Save Time ... how to reduce the number of instruments on ... design can be complicated, requiring multiple chemical measurements ... and deposition. Dedicated single and dual channel transmitters ... space. Additionally, installing and maintaining each transmitter, its ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Apiscent ... supplier of fine chemical ingredients to the global ... launch of its new website, Apiscent.com. , The ... Apiscent Labs, clean design, easy navigation, rotating images ... Apiscent Labs stand out. , The ...
(Date:11/22/2014)... 21, 2014 Prominent academics, leaders ... gather on December 3rd at Genetic Rx, a ... GeneticRx will take place at the Joseph B. ... will discuss the present and future of genetic ... and gene editing—as well as the treatment of ...
Breaking Biology Technology:SPIE Digital Library Now Available to High Schools, Two-Year Colleges at No or Low Cost 2New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... Lou Tornatzky, co-author of a white paper that spells out ... has all the pieces in place for an innovative economic ... during a July 10 luncheon program of the Wisconsin ... than did some of the nation's more notable technology locales ...
... mission of funding energy-saving technologies, and to avoid confusion ... Technology Transfer in Madison is changing its name to ... provides investment funding and business expertise to companies that ... bring their products and services to the market. ...
... technology provider GE Healthcare announced it has begun ... detection of cancer. , ,The agent, which uses positron emission ... or the formation of new blood vessels in the body. ... metastatic tumors in breast cancer patients, before and after chemotherapy. ...
Cached Biology Technology:Innovation expert says Milwaukee has all the tools 2Innovation expert says Milwaukee has all the tools 3Innovation expert says Milwaukee has all the tools 4
(Date:11/18/2014)... , Nov. 18, 2014  The Secure ... Industry Association today jointly announce the formation of ... release of its Identity and Biometric Entry ... The Framework received official support from BORDERPOL, the ... to improve and provide expertise regarding border security, ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
(Date:11/15/2014)... NEW YORK , Nov. 13, 2014  While we ... of technology Doctor McCoy used in "Star Trek" to gain ... and tools designed to work with smartphones and tablets for ... corners of the healthcare world. This may seem a tad ... are ready to adopt some of these technological opportunities into ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... brings experts to New York City from around ... on Cell Therapy for Cardiovascular Diseases. Dedicated to ... session will feature an in-depth review of cell-based ... cutting-edge research findings. Highlights include: ...
... In the latest issue of the journal Emerging ... in the hyperboreal tundra, in connection with the ... bacteria. These findings indicate that resistance to ... alarming prospect for future health care. The ...
... 11, 2008): Nucleonics, Inc., a privately held ... RNA interference (RNAi)-based therapeutics, announced today that the ... 1 human safety study of its experimental treatment ... B1000. NUC B1000 ( http://www.nucleonicsinc.com/products/hepb.html ) ...
Cached Biology News:Cell Therapy for Cardiovascular Diseases 2Cell Therapy for Cardiovascular Diseases 3High degree of resistance to antibiotics in Arctic birds 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 3
Request Info...
Recombinant Mouse Serpin A1/alpha-1-Antitrypsin, CF Protein Family: Coagulation, Serine Protease Regulators...
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble...
... Since the Flp-In System creates ... produce equivalent levels of the protein ... demonstrated in Figure 3. In this ... transferase (CAT) was subcloned into pcDNA5/FRT ...
Biology Products: